Return On Equity of INTERCEPT PHARMACEUTICALS, INC. from 30 Jun 2013 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2013 to 30 Sep 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Return On Equity for the quarter ending 30 Sep 2023 was -82%, a 19% increase year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Equity for 2022 was -164%, a 433% decline from 2021.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Equity for 2021 was 49%, a 82% decline from 2020.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Equity for 2020 was 268%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 -82% +19% +19% 01 Jul 2023 30 Sep 2023
Q2 2023 249% +225% +939% 01 Apr 2023 30 Jun 2023
Q1 2023 -812% -842% -2821% 01 Jan 2023 31 Mar 2023
Q4 2022 -164% -213% -433% 01 Oct 2022 31 Dec 2022
Q3 2022 -101% -160% -271% 01 Jul 2022 30 Sep 2022
Q2 2022 24% -73% -75% 01 Apr 2022 30 Jun 2022
Q1 2022 30% -125% -81% 01 Jan 2022 31 Mar 2022
Q4 2021 49% -219% -82% 01 Oct 2021 31 Dec 2021
Q3 2021 59% -609% -91% 01 Jul 2021 30 Sep 2021
Q2 2021 97% +2070% 01 Apr 2021 30 Jun 2021
Q1 2021 154% +585% 01 Jan 2021 31 Mar 2021
Q4 2020 268% +724% 01 Oct 2020 31 Dec 2020
Q3 2020 668% +1163% 01 Jul 2020 30 Sep 2020
Q2 2020 -1973% -1439% -269% 01 Apr 2020 30 Jun 2020
Q1 2020 -431% +185% +30% 01 Jan 2020 31 Mar 2020
Q4 2019 -456% +135% +23% 01 Oct 2019 31 Dec 2019
Q3 2019 -495% +149% +23% 01 Jul 2019 30 Sep 2019
Q2 2019 -534% +78% +13% 01 Apr 2019 30 Jun 2019
Q1 2019 -616% -42% -7.4% 01 Jan 2019 31 Mar 2019
Q4 2018 -591% -323% -121% 01 Oct 2018 31 Dec 2018
Q3 2018 -644% -468% -265% 01 Jul 2018 30 Sep 2018
Q2 2018 -613% -478% -353% 01 Apr 2018 30 Jun 2018
Q1 2018 -574% -465% -429% 01 Jan 2018 31 Mar 2018
Q4 2017 -268% -167% -165% 01 Oct 2017 31 Dec 2017
Q3 2017 -177% -97% -123% 01 Jul 2017 30 Sep 2017
Q2 2017 -135% -72% -115% 01 Apr 2017 30 Jun 2017
Q1 2017 -108% -58% -115% 01 Jan 2017 31 Mar 2017
Q4 2016 -101% -63% -168% 01 Oct 2016 31 Dec 2016
Q3 2016 -79% -45% -132% 01 Jul 2016 30 Sep 2016
Q2 2016 -63% -24% -60% 01 Apr 2016 30 Jun 2016
Q1 2016 -50% -24% -94% 01 Jan 2016 31 Mar 2016
Q4 2015 -38% +143% +79% 01 Oct 2015 31 Dec 2015
Q3 2015 -34% +183% +84% 01 Jul 2015 30 Sep 2015
Q2 2015 -39% +292% +88% 01 Apr 2015 30 Jun 2015
Q1 2015 -26% +868% +97% 01 Jan 2015 31 Mar 2015
Q4 2014 -180% -103% -133% 01 Oct 2014 31 Dec 2014
Q3 2014 -217% -114% -111% 01 Jul 2014 30 Sep 2014
Q2 2014 -332% -240% -260% 01 Apr 2014 30 Jun 2014
Q1 2014 -894% 01 Jan 2014 31 Mar 2014
Q4 2013 -77% 01 Oct 2013 31 Dec 2013
Q3 2013 -103% 01 Jul 2013 30 Sep 2013
Q2 2013 -92% 01 Apr 2013 30 Jun 2013

INTERCEPT PHARMACEUTICALS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -164% -213% -433% 01 Jan 2022 31 Dec 2022
2021 49% -219% -82% 01 Jan 2021 31 Dec 2021
2020 268% +724% 01 Jan 2020 31 Dec 2020
2019 -456% +135% +23% 01 Jan 2019 31 Dec 2019
2018 -591% -323% -121% 01 Jan 2018 31 Dec 2018
2017 -268% -167% -165% 01 Jan 2017 31 Dec 2017
2016 -101% -63% -168% 01 Jan 2016 31 Dec 2016
2015 -38% +143% +79% 01 Jan 2015 31 Dec 2015
2014 -180% -103% -133% 01 Jan 2014 31 Dec 2014
2013 -77% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.